Merck: FDA won't OK its combo cholesterol drug now

Monday, March 5, 2012 - 17:30 in Health & Medicine

TRENTON, N.J. (AP) -- Federal regulators have rejected Merck & Co.'s new combination cholesterol drug, which includes a generic version of the mega-blockbuster Lipitor - at least for now....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net